EP3727365A4 - MODIFIED RELEASE FORMULATIONS BY FLURBIPROFEN - Google Patents

MODIFIED RELEASE FORMULATIONS BY FLURBIPROFEN Download PDF

Info

Publication number: EP3727365A4
Authority: EP; European Patent Office
Prior art keywords: flurbiprofen; release formulations; modified release; modified; formulations
Prior art date: 2017-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

EP18916470.0A

Other languages

German (de)

French (fr)

Other versions

EP3727365A2 (en

Inventor

Ali TÜRKYILMAZ

Nur PEHLIVAN AKALIN

Kerim AKKAYA

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanovel Ilac Sanayi ve Ticaret AS

Original Assignee

Sanovel Ilac Sanayi ve Ticaret AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-12-21

Filing date

2018-12-20

Publication date

2021-06-16

2018-12-20 Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS

2020-10-28 Publication of EP3727365A2 publication Critical patent/EP3727365A2/en

2021-06-16 Publication of EP3727365A4 publication Critical patent/EP3727365A4/en

Status Pending legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

EP18916470.0A 2017-12-21 2018-12-20 MODIFIED RELEASE FORMULATIONS BY FLURBIPROFEN Pending EP3727365A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
TR2017/21036A TR201721036A2 (en)	2017-12-21	2017-12-21	MODULATED EMISSION FORMULATIONS OF FLURBIPROPHEN
PCT/TR2018/050846 WO2019209217A2 (en)	2017-12-21	2018-12-20	Modified release formulations of flurbiprofen

Publications (2)

Publication Number	Publication Date
EP3727365A2 EP3727365A2 (en)	2020-10-28
EP3727365A4 true EP3727365A4 (en)	2021-06-16

Family

ID=67901210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP18916470.0A Pending EP3727365A4 (en)	2017-12-21	2018-12-20	MODIFIED RELEASE FORMULATIONS BY FLURBIPROFEN

Country Status (3)

Country	Link
EP (1)	EP3727365A4 (en)
TR (1)	TR201721036A2 (en)
WO (1)	WO2019209217A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US12343340B2 (en)	2020-12-31	2025-07-01	Soin Therapeutics Llc	Methods of using low dose naltrexone to treat chronic pain
EP4536220A1 (en) *	2022-06-13	2025-04-16	Soin Therapeutics LLC	Methods of using low dose naltrexone to treat chronic pain

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993010771A1 (en) *	1991-12-05	1993-06-10	Alfatec-Pharma Gmbh	Slow-release flurbiprofen-containing medicament and its use
US5556638A (en) *	1991-12-05	1996-09-17	Alfatec Pharma Gmbh	Flurbiprofen-containing immediate-effect medicament and its use
EP1064938A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2696063C (en) *	2007-08-15	2014-05-06	Mcneil-Ppc, Inc.	Immediate release and sustained release ibuprofen dosing form
WO2016063055A1 (en) *	2014-10-21	2016-04-28	Reckitt Benckiser Llc	Pharmaceutical capsule containing at least two tablets

2017
- 2017-12-21 TR TR2017/21036A patent/TR201721036A2/en unknown
2018
- 2018-12-20 EP EP18916470.0A patent/EP3727365A4/en active Pending
- 2018-12-20 WO PCT/TR2018/050846 patent/WO2019209217A2/en unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993010771A1 (en) *	1991-12-05	1993-06-10	Alfatec-Pharma Gmbh	Slow-release flurbiprofen-containing medicament and its use
US5556638A (en) *	1991-12-05	1996-09-17	Alfatec Pharma Gmbh	Flurbiprofen-containing immediate-effect medicament and its use
EP1064938A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Pharmaceutical dosage forms for controlled release producing at least a timed pulse

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAVIES NEAL M.: "Clinical Pharmacokinetics of Flurbiprofen and its Enantiomers :", vol. 28, no. 2, 1 February 1995 (1995-02-01), NZ, pages 100 - 114, XP055801584, ISSN: 0312-5963, Retrieved from the Internet <URL:http://dx.doi.org/10.2165/00003088-199528020-00002> DOI: 10.2165/00003088-199528020-00002 *
See also references of WO2019209217A2 *

Also Published As

Publication number	Publication date
WO2019209217A2 (en)	2019-10-31
TR201721036A2 (en)	2019-07-22
EP3727365A2 (en)	2020-10-28
WO2019209217A3 (en)	2020-01-23

Publication	Publication Date	Title
IL273541A (en)	2020-05-31	formulations
EP3722358A4 (en)	2021-08-25	COMPOSITION
DK3697376T3 (en)	2022-03-14	COMPOSITION
MA50657A (en)	2020-08-05	NIRAPARIB FORMULATIONS
LT3283080T (en)	2020-05-25	C9ORF72 EXPRESSION MODULATION COMPOSITIONS
DK3416996T3 (en)	2020-07-06	HARDLY COMPOSITION
EP3415008A4 (en)	2019-09-11	GERMICIDE COMPOSITION
EP3580321A4 (en)	2020-12-02	DETERGENT FORMULATIONS
DK3528902T3 (en)	2021-07-05	RINGEGEL COMPOSITION
EP3536734A4 (en)	2019-10-30	POLYMERIZABLE COMPOSITION
EP3364945C0 (en)	2024-12-04	FIXED FORMULATIONS
EP3367997A4 (en)	2019-07-03	NEW OCCLUSIVE FORMULATIONS
DK3651736T3 (en)	2021-09-27	LONG-TERM EFFECTIVE FORMULATIONS
EP3560512A4 (en)	2020-07-22	HERPES-ZOSTER VACCINE COMPOSITION
IL266867A (en)	2019-07-31	Nano-particle formulations
EP3480228A4 (en)	2020-03-11	COMPOSITION
HUE063178T2 (en)	2023-12-28	Copanlisib formulations
EP3398975A4 (en)	2019-08-21	PHOTOSENSITIVE COMPOSITION
EP3556804A4 (en)	2019-11-13	COMPOSITION
EP3600279A4 (en)	2020-12-16	1-AMINO-1-CYCLOPROPANCARBONIC ACID FORMULATIONS
EP3443034C0 (en)	2024-04-10	COMPOSITION
DK3416502T3 (en)	2021-10-18	GLYCEMIC-REDUCING COMPOSITION
EP3335688A4 (en)	2019-02-13	POLYMERIZABLE DENTAL COMPOSITION
EP3675653C0 (en)	2024-03-13	ANTIMYCOTOXIN COMPOSITION
DK3609464T3 (en)	2021-08-30	XANTHOHUMOL-BASED COMPOSITIONS

Legal Events

Date	Code	Title	Description
2019-11-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2020-09-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2020-09-25	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2020-10-28	17P	Request for examination filed	Effective date: 20200718
2020-10-28	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2020-10-28	AX	Request for extension of the european patent	Extension state: BA ME
2021-03-31	DAV	Request for validation of the european patent (deleted)
2021-03-31	DAX	Request for extension of the european patent (deleted)
2021-06-16	A4	Supplementary search report drawn up and despatched	Effective date: 20210514
2021-06-16	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/192 20060101AFI20210508BHEP Ipc: A61K 9/48 20060101ALI20210508BHEP Ipc: A61K 9/50 20060101ALI20210508BHEP
2023-06-30	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-08-02	17Q	First examination report despatched	Effective date: 20230629
2023-08-16	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230708
2025-01-01	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
2025-01-08	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SANOVEL ILAC SANAYI VE TICARET A.S.